✦ LIBER ✦

Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium

✍ Scribed by Trabert, B.; Ness, R. B.; Lo-Ciganic, W.-H.; Murphy, M. A.; Goode, E. L.; Poole, E. M.; Brinton, L. A.; Webb, P. M.; Nagle, C. M.; Jordan, S. J.; Risch, H. A.; Rossing, M. A.; Doherty, J. A.; Goodman, M. T.; Lurie, G.; Kjaer, S. K.; Hogdall, E.; Jensen, A.; Cramer, D. W.; Terry, K. L.; Vitonis, A.; Bandera, E. V.; Olson, S.; King, M. G.; Chandran, U.; Anton-Culver, H.; Ziogas, A.; Menon, U.; Gayther, S. A.; Ramus, S. J.; Gentry-Maharaj, A.; Wu, A. H.; Pearce, C. L.; Pike, M. C.; Berchuck, A.; Schildkraut, J. M.; Wentzensen, N.

Book ID: 126706505
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 390 KB
Volume: 106
Category: Article
ISSN: 0027-8874
DOI: 10.1093/jnci/djt431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progesterone receptor variation and risk

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis

✍ Pearce, C L; Wu, A H; Gayther, S A; Bale, A E; Beck, P A; Beesley, J; Chanock, S 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 171 KB

Vitamin D receptor rs2228570 polymorphis

Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium

✍ Galina Lurie; Lynne R. Wilkens; Pamela J. Thompson; Michael E. Carney; Rachel T. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 225 KB 👁 1 views

## Abstract The association of invasive ovarian carcinoma risk with the functional polymorphism rs2228570 (__aka__ rs10735810; __Fok__I polymorphism) in the vitamin D receptor (__VDR__) gene was examined in 1820 white non‐Hispanic cases and 3479 controls in a pooled analysis of five population‐base

Non-steroidal anti-inflammatory drug use

Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

✍ Siobhan Sutcliffe; Robert L. Grubb III; Elizabeth A. Platz; Lawrence R. Ragard; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB